Purchase Order 19AQMM26P0214
Award Date 2/1/26
Potential Completion Date 1/31/31
Potential Value $237K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Milwaukee, WI 53213, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. government awarded a definitive contract valued at $161,650 to Shoreland Inc. on July 31, 2022, for TRAVAX, a computer resource and subscription license providing health professionals and overseas travelers with integrated health and travel information sourced from the Centers for Disease Control and Prevention, World Health Organization, U.S. Department of State, and other U.S. government resources. The firm fixed price contract, which will be completed by July 30, 2027, was awarded...
- The Peace Corps awarded a $82.8K firm fixed price purchase order to Shoreland Inc. for TRAVAX subscription services under contract P00004 Exercise OY3. The award, announced on April 5, 2023, extends through April 4, 2028, and carries no set-aside designation. TRAVAX is a clinical decision support and travel health guidance software platform that provides healthcare providers and government agencies with comprehensive immunization tracking, vaccination management, and travel health information....
- Merck Sharp & Dohme LLC (Merck) received a $18,000 firm fixed price blanket purchase agreement (BPA) call award from the Federal Bureau of Investigation Headquarters Division for travel vaccines. The contract was awarded on February 22, 2026, with an ultimate completion date of February 21, 2027. Performance will be conducted at Merck's facility in North Wales, Pennsylvania. This award represents a delivery order under Merck's existing $775,000 BPA with the FBI Headquarters Division for...
- The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a $174,976 firm fixed-price purchase order to Valneva USA, Inc. (doing business as Intercell USA Inc.) for Japanese encephalitis vaccine on January 12, 2026. The contract, designated as a Total Small Business set-aside, calls for delivery to Bethesda, Maryland, with an ultimate completion date of January 12, 2026. Valneva USA, a subsidiary of French vaccine manufacturer Valneva SE, is a established...
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a $54,102 delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule to Valneva USA, Inc., doing business as Intercell USA Inc., a subsidiary of Valneva. The firm fixed price order is for delivery of IXIARO vaccine stock, with performance at the agency's Potomac, Maryland location through December 24, 2021. No set-aside designation was applied to this order placed under the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Imovax Rabies vaccine vials valued at $6,682.50. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 27, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) from the Defense Logistics Agency (DLA) Troop Support Medical is a delivery order under an Indefinite Delivery Contract (IDC) valued at $1,817.10. The contract is for the supply of PEDVAXHIB vaccine vials, a pharmaceutical product used for immunization. This delivery order has a firm fixed price and is set to be completed by November 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that plays a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for HAVRIX 1440 UN 1ML vaccines on August 11, 2025, with a ceiling value of $9,483.80 and an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under the company's larger...
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a $72,136 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Valneva USA, Inc., doing business as Intercell USA Inc., a subsidiary of Valneva. The firm fixed price order is for delivery of IXIARO vaccine stock, with performance at the agency's Potomac, Maryland location through December 4, 2021. No set-aside designation was applied to this order placed under GSA...
- The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a $172,232 firm fixed-price purchase order to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 6, 2026, for Japanese encephalitis vaccine to protect State Department personnel and their families. The contract carries a total small business set-aside designation and is scheduled for completion by January 6, 2026, with performance taking place in Bethesda, Maryland. Valneva USA is a...